nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—CYP3A4—Temozolomide—malignant glioma	0.608	1	CbGbCtD
Lomitapide—MTTP—blood vessel—malignant glioma	0.039	0.494	CbGeAlD
Lomitapide—MTTP—embryo—malignant glioma	0.0233	0.295	CbGeAlD
Lomitapide—Antrafenine—PTGS1—malignant glioma	0.0149	0.636	CrCbGaD
Lomitapide—Transaminases increased—Carmustine—malignant glioma	0.0107	0.041	CcSEcCtD
Lomitapide—Antrafenine—PTGS2—malignant glioma	0.00854	0.364	CrCbGaD
Lomitapide—Hepatotoxicity—Carmustine—malignant glioma	0.0084	0.0323	CcSEcCtD
Lomitapide—Hepatotoxicity—Temozolomide—malignant glioma	0.00812	0.0312	CcSEcCtD
Lomitapide—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00762	0.0293	CcSEcCtD
Lomitapide—Drug interaction—Carmustine—malignant glioma	0.00699	0.0269	CcSEcCtD
Lomitapide—Gait disturbance—Carmustine—malignant glioma	0.00665	0.0256	CcSEcCtD
Lomitapide—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00663	0.0255	CcSEcCtD
Lomitapide—Gait disturbance—Temozolomide—malignant glioma	0.00642	0.0247	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00523	0.0201	CcSEcCtD
Lomitapide—Gastroenteritis—Temozolomide—malignant glioma	0.00513	0.0198	CcSEcCtD
Lomitapide—Nasal congestion—Temozolomide—malignant glioma	0.005	0.0192	CcSEcCtD
Lomitapide—Liver function test abnormal—Carmustine—malignant glioma	0.00435	0.0167	CcSEcCtD
Lomitapide—Dehydration—Temozolomide—malignant glioma	0.00423	0.0163	CcSEcCtD
Lomitapide—Dry skin—Temozolomide—malignant glioma	0.00417	0.0161	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0041	0.0158	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00401	0.0154	CcSEcCtD
Lomitapide—Abdominal distension—Temozolomide—malignant glioma	0.00396	0.0152	CcSEcCtD
Lomitapide—Weight decreased—Temozolomide—malignant glioma	0.00356	0.0137	CcSEcCtD
Lomitapide—Infestation NOS—Temozolomide—malignant glioma	0.00351	0.0135	CcSEcCtD
Lomitapide—Infestation—Temozolomide—malignant glioma	0.00351	0.0135	CcSEcCtD
Lomitapide—ABCB1—blood vessel—malignant glioma	0.00344	0.0436	CbGeAlD
Lomitapide—Hepatobiliary disease—Temozolomide—malignant glioma	0.00332	0.0128	CcSEcCtD
Lomitapide—Sinusitis—Temozolomide—malignant glioma	0.00329	0.0127	CcSEcCtD
Lomitapide—Connective tissue disorder—Carmustine—malignant glioma	0.0032	0.0123	CcSEcCtD
Lomitapide—Urinary tract disorder—Temozolomide—malignant glioma	0.00311	0.012	CcSEcCtD
Lomitapide—Connective tissue disorder—Temozolomide—malignant glioma	0.00309	0.0119	CcSEcCtD
Lomitapide—Urethral disorder—Temozolomide—malignant glioma	0.00309	0.0119	CcSEcCtD
Lomitapide—Eye disorder—Carmustine—malignant glioma	0.00304	0.0117	CcSEcCtD
Lomitapide—Eye disorder—Temozolomide—malignant glioma	0.00294	0.0113	CcSEcCtD
Lomitapide—Cardiac disorder—Temozolomide—malignant glioma	0.00292	0.0112	CcSEcCtD
Lomitapide—Mediastinal disorder—Temozolomide—malignant glioma	0.00284	0.0109	CcSEcCtD
Lomitapide—Malnutrition—Carmustine—malignant glioma	0.00284	0.0109	CcSEcCtD
Lomitapide—Chills—Temozolomide—malignant glioma	0.00282	0.0109	CcSEcCtD
Lomitapide—Back pain—Carmustine—malignant glioma	0.00274	0.0106	CcSEcCtD
Lomitapide—Malnutrition—Temozolomide—malignant glioma	0.00274	0.0105	CcSEcCtD
Lomitapide—Back pain—Temozolomide—malignant glioma	0.00265	0.0102	CcSEcCtD
Lomitapide—Anaemia—Carmustine—malignant glioma	0.00262	0.0101	CcSEcCtD
Lomitapide—Ill-defined disorder—Temozolomide—malignant glioma	0.00254	0.00979	CcSEcCtD
Lomitapide—Anaemia—Temozolomide—malignant glioma	0.00253	0.00975	CcSEcCtD
Lomitapide—Malaise—Temozolomide—malignant glioma	0.00247	0.00951	CcSEcCtD
Lomitapide—Vertigo—Temozolomide—malignant glioma	0.00246	0.00948	CcSEcCtD
Lomitapide—Palpitations—Temozolomide—malignant glioma	0.00242	0.00932	CcSEcCtD
Lomitapide—Myalgia—Carmustine—malignant glioma	0.00241	0.00929	CcSEcCtD
Lomitapide—Chest pain—Carmustine—malignant glioma	0.00241	0.00929	CcSEcCtD
Lomitapide—Arthralgia—Temozolomide—malignant glioma	0.00233	0.00898	CcSEcCtD
Lomitapide—Myalgia—Temozolomide—malignant glioma	0.00233	0.00898	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00232	0.00892	CcSEcCtD
Lomitapide—Discomfort—Temozolomide—malignant glioma	0.00231	0.00887	CcSEcCtD
Lomitapide—Infection—Carmustine—malignant glioma	0.0023	0.00885	CcSEcCtD
Lomitapide—Dry mouth—Temozolomide—malignant glioma	0.00228	0.00878	CcSEcCtD
Lomitapide—Infection—Temozolomide—malignant glioma	0.00222	0.00855	CcSEcCtD
Lomitapide—Nervous system disorder—Temozolomide—malignant glioma	0.00219	0.00844	CcSEcCtD
Lomitapide—Skin disorder—Temozolomide—malignant glioma	0.00217	0.00836	CcSEcCtD
Lomitapide—Hyperhidrosis—Temozolomide—malignant glioma	0.00216	0.00832	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00211	0.00811	CcSEcCtD
Lomitapide—Paraesthesia—Carmustine—malignant glioma	0.00208	0.008	CcSEcCtD
Lomitapide—Somnolence—Carmustine—malignant glioma	0.00206	0.00792	CcSEcCtD
Lomitapide—ABCB1—embryo—malignant glioma	0.00205	0.026	CbGeAlD
Lomitapide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00204	0.00784	CcSEcCtD
Lomitapide—Decreased appetite—Carmustine—malignant glioma	0.00201	0.00774	CcSEcCtD
Lomitapide—Paraesthesia—Temozolomide—malignant glioma	0.00201	0.00773	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Carmustine—malignant glioma	0.002	0.00769	CcSEcCtD
Lomitapide—Somnolence—Temozolomide—malignant glioma	0.00199	0.00765	CcSEcCtD
Lomitapide—Constipation—Carmustine—malignant glioma	0.00198	0.00762	CcSEcCtD
Lomitapide—Dyspepsia—Temozolomide—malignant glioma	0.00197	0.00758	CcSEcCtD
Lomitapide—Decreased appetite—Temozolomide—malignant glioma	0.00194	0.00748	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00193	0.00743	CcSEcCtD
Lomitapide—Fatigue—Temozolomide—malignant glioma	0.00193	0.00742	CcSEcCtD
Lomitapide—Constipation—Temozolomide—malignant glioma	0.00191	0.00736	CcSEcCtD
Lomitapide—Feeling abnormal—Carmustine—malignant glioma	0.00191	0.00734	CcSEcCtD
Lomitapide—Gastrointestinal pain—Carmustine—malignant glioma	0.00189	0.00728	CcSEcCtD
Lomitapide—Feeling abnormal—Temozolomide—malignant glioma	0.00184	0.00709	CcSEcCtD
Lomitapide—Abdominal pain—Carmustine—malignant glioma	0.00183	0.00704	CcSEcCtD
Lomitapide—Body temperature increased—Carmustine—malignant glioma	0.00183	0.00704	CcSEcCtD
Lomitapide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00183	0.00704	CcSEcCtD
Lomitapide—ABCB1—retina—malignant glioma	0.00182	0.023	CbGeAlD
Lomitapide—MTTP—Circadian rythm related genes—NTRK3—malignant glioma	0.00178	0.0602	CbGpPWpGaD
Lomitapide—Abdominal pain—Temozolomide—malignant glioma	0.00177	0.0068	CcSEcCtD
Lomitapide—Body temperature increased—Temozolomide—malignant glioma	0.00177	0.0068	CcSEcCtD
Lomitapide—ABCB1—telencephalon—malignant glioma	0.00167	0.0212	CbGeAlD
Lomitapide—Asthenia—Carmustine—malignant glioma	0.00166	0.00639	CcSEcCtD
Lomitapide—Asthenia—Temozolomide—malignant glioma	0.0016	0.00618	CcSEcCtD
Lomitapide—Diarrhoea—Carmustine—malignant glioma	0.00158	0.00609	CcSEcCtD
Lomitapide—Dizziness—Carmustine—malignant glioma	0.00153	0.00589	CcSEcCtD
Lomitapide—Diarrhoea—Temozolomide—malignant glioma	0.00153	0.00589	CcSEcCtD
Lomitapide—Dizziness—Temozolomide—malignant glioma	0.00148	0.00569	CcSEcCtD
Lomitapide—Vomiting—Carmustine—malignant glioma	0.00147	0.00566	CcSEcCtD
Lomitapide—Headache—Carmustine—malignant glioma	0.00145	0.00558	CcSEcCtD
Lomitapide—Vomiting—Temozolomide—malignant glioma	0.00142	0.00547	CcSEcCtD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—CAV1—malignant glioma	0.00141	0.0475	CbGpPWpGaD
Lomitapide—Headache—Temozolomide—malignant glioma	0.0014	0.00539	CcSEcCtD
Lomitapide—Nausea—Carmustine—malignant glioma	0.00137	0.00529	CcSEcCtD
Lomitapide—CYP3A4—central nervous system—malignant glioma	0.00134	0.017	CbGeAlD
Lomitapide—Nausea—Temozolomide—malignant glioma	0.00133	0.00511	CcSEcCtD
Lomitapide—ABCB1—medulla oblongata—malignant glioma	0.00131	0.0166	CbGeAlD
Lomitapide—ABCB1—midbrain—malignant glioma	0.0012	0.0152	CbGeAlD
Lomitapide—ABCB1—spinal cord—malignant glioma	0.00117	0.0148	CbGeAlD
Lomitapide—ABCB1—central nervous system—malignant glioma	0.000949	0.012	CbGeAlD
Lomitapide—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.000943	0.0319	CbGpPWpGaD
Lomitapide—ABCB1—cerebellum—malignant glioma	0.000928	0.0118	CbGeAlD
Lomitapide—MTTP—Circadian rythm related genes—PML—malignant glioma	0.000911	0.0308	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TOP2A—malignant glioma	0.000833	0.0282	CbGpPWpGaD
Lomitapide—ABCB1—brain—malignant glioma	0.000754	0.00955	CbGeAlD
Lomitapide—MTTP—Metabolism—RTEL1—malignant glioma	0.000706	0.0239	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—NTRK1—malignant glioma	0.000648	0.0219	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.000638	0.0216	CbGpPWpGaD
Lomitapide—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000604	0.0204	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000575	0.0194	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—NCOR1—malignant glioma	0.000567	0.0192	CbGpPWpGaD
Lomitapide—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000542	0.0183	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.000537	0.0182	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000505	0.0171	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000488	0.0165	CbGpPWpGaD
Lomitapide—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00047	0.0159	CbGpPWpGaD
Lomitapide—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00044	0.0149	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—PPARG—malignant glioma	0.000406	0.0137	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—COX8A—malignant glioma	0.000406	0.0137	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00039	0.0132	CbGpPWpGaD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000372	0.0126	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000363	0.0123	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.00036	0.0122	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000354	0.012	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ASMT—malignant glioma	0.000345	0.0117	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000337	0.0114	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—BCAN—malignant glioma	0.000324	0.011	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—GDNF—malignant glioma	0.000312	0.0105	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL12A—malignant glioma	0.000285	0.00963	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—PTEN—malignant glioma	0.000279	0.00942	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.000268	0.00906	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—IDH2—malignant glioma	0.000261	0.00884	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000246	0.00833	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP2B6—malignant glioma	0.000246	0.00831	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000241	0.00815	CbGpPWpGaD
Lomitapide—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000239	0.00808	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000225	0.0076	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—IDH1—malignant glioma	0.000225	0.0076	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.000222	0.00751	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000222	0.0075	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SPHK1—malignant glioma	0.000217	0.00735	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP2C18—malignant glioma	0.000213	0.0072	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-C—malignant glioma	0.00021	0.00712	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000201	0.00679	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000195	0.00659	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000192	0.00651	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TP53—malignant glioma	0.00019	0.00643	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000184	0.00622	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000184	0.00621	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000183	0.00619	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000182	0.00616	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.000179	0.00605	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000177	0.00597	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTT1—malignant glioma	0.000172	0.00583	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000162	0.00548	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS1—malignant glioma	0.000161	0.00546	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000161	0.00544	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000158	0.00534	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—BCHE—malignant glioma	0.00015	0.00507	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SLC5A5—malignant glioma	0.000148	0.00501	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00014	0.00474	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000139	0.0047	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000133	0.0045	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000132	0.00445	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000127	0.0043	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000125	0.00424	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000124	0.00421	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000123	0.00416	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000121	0.0041	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00012	0.00405	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTP1—malignant glioma	0.000119	0.00404	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000117	0.00394	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CAT—malignant glioma	0.000116	0.00393	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.000115	0.0039	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000113	0.00383	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NCOR1—malignant glioma	0.00011	0.00371	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000104	0.00351	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD80—malignant glioma	9.73e-05	0.00329	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	9.68e-05	0.00327	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	9.55e-05	0.00323	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	9.5e-05	0.00321	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	9.47e-05	0.0032	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CAV1—malignant glioma	8.95e-05	0.00302	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	8.66e-05	0.00293	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.55e-05	0.00289	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	8.4e-05	0.00284	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	8.28e-05	0.0028	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CG—malignant glioma	8.15e-05	0.00276	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPARG—malignant glioma	7.87e-05	0.00266	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	7.83e-05	0.00265	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—RTEL1—malignant glioma	7.73e-05	0.00261	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IFNG—malignant glioma	7.69e-05	0.0026	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	7.57e-05	0.00256	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	7.39e-05	0.0025	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	7.37e-05	0.00249	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	7.27e-05	0.00246	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CD—malignant glioma	7.16e-05	0.00242	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CXCL8—malignant glioma	7.15e-05	0.00242	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	6.87e-05	0.00232	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL1B—malignant glioma	6.86e-05	0.00232	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP3—malignant glioma	6.85e-05	0.00231	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL2—malignant glioma	6.84e-05	0.00231	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	6.81e-05	0.0023	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTT1—malignant glioma	6.79e-05	0.0023	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	6.71e-05	0.00227	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—PTGS1—malignant glioma	6.36e-05	0.00215	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CB—malignant glioma	6.24e-05	0.00211	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—malignant glioma	6.19e-05	0.00209	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	6.18e-05	0.00209	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—malignant glioma	5.81e-05	0.00196	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	5.53e-05	0.00187	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTEN—malignant glioma	5.4e-05	0.00182	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—malignant glioma	4.98e-05	0.00168	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	4.95e-05	0.00167	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	4.79e-05	0.00162	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—RTEL1—malignant glioma	4.76e-05	0.00161	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	4.74e-05	0.0016	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.71e-05	0.00159	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.64e-05	0.00157	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—COX8A—malignant glioma	4.44e-05	0.0015	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	4.28e-05	0.00145	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	4.04e-05	0.00136	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.83e-05	0.0013	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CA—malignant glioma	3.81e-05	0.00129	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.78e-05	0.00128	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ASMT—malignant glioma	3.77e-05	0.00128	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	3.77e-05	0.00128	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.76e-05	0.00127	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.72e-05	0.00126	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	3.64e-05	0.00123	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—BCAN—malignant glioma	3.55e-05	0.0012	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.46e-05	0.00117	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.38e-05	0.00114	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.3e-05	0.00111	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.17e-05	0.00107	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AKT1—malignant glioma	3.11e-05	0.00105	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.87e-05	0.000969	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—IDH2—malignant glioma	2.86e-05	0.000967	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—COX8A—malignant glioma	2.73e-05	0.000924	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2B6—malignant glioma	2.69e-05	0.000909	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.64e-05	0.000892	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.58e-05	0.000872	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—IDH1—malignant glioma	2.46e-05	0.000831	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.46e-05	0.000831	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.44e-05	0.000824	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SPHK1—malignant glioma	2.38e-05	0.000804	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2C18—malignant glioma	2.33e-05	0.000788	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ASMT—malignant glioma	2.32e-05	0.000786	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.24e-05	0.000757	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—BCAN—malignant glioma	2.19e-05	0.000739	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.17e-05	0.000732	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTT1—malignant glioma	1.89e-05	0.000637	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.83e-05	0.000619	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS1—malignant glioma	1.77e-05	0.000597	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—IDH2—malignant glioma	1.76e-05	0.000596	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.66e-05	0.00056	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—BCHE—malignant glioma	1.64e-05	0.000555	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC5A5—malignant glioma	1.62e-05	0.000548	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—IDH1—malignant glioma	1.51e-05	0.000512	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.49e-05	0.000505	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SPHK1—malignant glioma	1.47e-05	0.000496	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.44e-05	0.000486	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTP1—malignant glioma	1.31e-05	0.000442	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CAT—malignant glioma	1.27e-05	0.00043	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NCOR1—malignant glioma	1.2e-05	0.000406	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTT1—malignant glioma	1.16e-05	0.000393	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS1—malignant glioma	1.09e-05	0.000368	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—BCHE—malignant glioma	1.01e-05	0.000342	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.99e-06	0.000338	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CAV1—malignant glioma	9.79e-06	0.000331	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CG—malignant glioma	8.92e-06	0.000301	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARG—malignant glioma	8.61e-06	0.000291	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTP1—malignant glioma	8.05e-06	0.000272	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CD—malignant glioma	7.84e-06	0.000265	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CAT—malignant glioma	7.83e-06	0.000265	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NCOR1—malignant glioma	7.4e-06	0.00025	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CB—malignant glioma	6.83e-06	0.000231	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—malignant glioma	6.77e-06	0.000229	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CAV1—malignant glioma	6.03e-06	0.000204	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTEN—malignant glioma	5.9e-06	0.0002	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.49e-06	0.000186	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARG—malignant glioma	5.3e-06	0.000179	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.83e-06	0.000163	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.21e-06	0.000142	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—malignant glioma	4.17e-06	0.000141	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CA—malignant glioma	4.16e-06	0.000141	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTEN—malignant glioma	3.64e-06	0.000123	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKT1—malignant glioma	3.4e-06	0.000115	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.57e-06	8.67e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKT1—malignant glioma	2.1e-06	7.09e-05	CbGpPWpGaD
